Who We Are

Terumo (TSE:4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for more than 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. Founded as a Japanese thermometer manufacturer in 1921, Terumo has been supporting healthcare around the world ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Introducing Terumo Group

Corporate Profile

Company Name Terumo Corporation
Head Office 2-44-1 Hatagaya, Shibuya-ku, Tokyo, 151-0072 Japan Tel. +81-3-3374-8111
Date of Establishment 1921
Corporate Stock Prime Market of Tokyo Stock Exchange (Code: 4543)
Capital Stock 38.7 billion yen
Revenue 820.2 billion yen (for FYE Mar. 2023)
The Latest Financial Results >
Representative Directors Toshiaki Takagi, Chairman of the Board
Hikaru Samejima, President and Chief Executive Officer 
Number of Employees 30,207 (Consolidated)
Main Business Manufacturing and sales of medical products and equipment, including pharmaceuticals, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers.
Global Network Global Network >

Corporate Guide Brochure

Terumo Corporate Guide 2023